Literature DB >> 32102909

Mouth-Level Nicotine Intake Estimates from Discarded Filter Butts to Examine Compensatory Smoking in Low Nicotine Cigarettes.

Tracy T Smith1, Joseph S Koopmeiners2, Dorothy K Hatsukami3, Katelyn M Tessier4, Neal L Benowitz5, Sharon E Murphy6, Andrew A Strasser7, Jennifer W Tidey8, Benjamin C Blount9, Liza Valentin9, Roberto Bravo Cardenas9, Clifford Watson9, James L Pirkle9, Eric C Donny10.   

Abstract

BACKGROUND: A mandated reduction in the nicotine content of cigarettes could reduce smoking rate and prevalence. However, one concern is that smokers may compensate by increasing the intensity with which they smoke each cigarette to obtain more nicotine. This study assessed whether smokers engage in compensatory smoking by estimating the mouth-level nicotine intake of low nicotine cigarettes smoked during a clinical trial.
METHODS: Smokers were randomly assigned to receive cigarettes with one of five nicotine contents for 6 weeks. An additional group received a cigarette with the lowest nicotine content, but an increased tar yield. The obtained mouth-level nicotine intake from discarded cigarette butts for a subset of participants (51-70/group) was estimated using solanesol as described previously. A compensation index was calculated for each group to estimate the proportion of nicotine per cigarette recovered through changes in smoking intensity.
RESULTS: There was no significant increase in smoking intensity for any of the reduced nicotine cigarettes as measured by the compensation index (an estimated 0.4% of the nicotine lost was recovered in the lowest nicotine group; 95% confidence interval, -0.1 to 1.2). There was a significant decrease in smoking intensity for very low nicotine content cigarettes with increased tar yield.
CONCLUSIONS: Reductions in nicotine content did not result in compensatory changes in how intensively participants smoked research cigarettes. IMPACT: Combined with data from clinical trials showing a reduction in cigarettes smoked per day, these data suggest that a reduction in nicotine content is unlikely to result in increased smoke exposure. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32102909      PMCID: PMC7100998          DOI: 10.1158/1055-9965.EPI-19-0905

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  21 in total

1.  Development of a method to assess cigarette smoke intake.

Authors:  Clifford Watson; Joan McCraw; Gregory Polzin; David Ashley; Dana Barr
Journal:  Environ Sci Technol       Date:  2004-01-01       Impact factor: 9.028

2.  Randomized Trial of Reduced-Nicotine Standards for Cigarettes.

Authors:  Eric C Donny; Rachel L Denlinger; Jennifer W Tidey; Joseph S Koopmeiners; Neal L Benowitz; Ryan G Vandrey; Mustafa al'Absi; Steven G Carmella; Paul M Cinciripini; Sarah S Dermody; David J Drobes; Stephen S Hecht; Joni Jensen; Tonya Lane; Chap T Le; F Joseph McClernon; Ivan D Montoya; Sharon E Murphy; Jason D Robinson; Maxine L Stitzer; Andrew A Strasser; Hilary Tindle; Dorothy K Hatsukami
Journal:  N Engl J Med       Date:  2015-10       Impact factor: 91.245

3.  Nicotine intake and dose response when smoking reduced-nicotine content cigarettes.

Authors:  Neal L Benowitz; Peyton Jacob; Brenda Herrera
Journal:  Clin Pharmacol Ther       Date:  2006-12       Impact factor: 6.875

4.  Estimating smokers' mouth-level exposure to select mainstream smoke constituents from discarded cigarette filter butts.

Authors:  Gregory M Polzin; Weijia Wu; Xizheng Yan; Joan M McCraw; Shadeed Abdul-Salaam; Ameer D Tavakoli; Liqin Zhang; David L Ashley; Clifford H Watson
Journal:  Nicotine Tob Res       Date:  2009-06-18       Impact factor: 4.244

5.  Transient compensatory smoking in response to placebo cigarettes.

Authors:  David A Macqueen; Bryan W Heckman; Melissa D Blank; Kate Janse Van Rensburg; David E Evans; David J Drobes
Journal:  Psychopharmacology (Berl)       Date:  2012-03-20       Impact factor: 4.530

6.  New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure.

Authors:  Andrew A Strasser; Caryn Lerman; Paul M Sanborn; Wallace B Pickworth; Eric A Feldman
Journal:  Drug Alcohol Depend       Date:  2006-08-22       Impact factor: 4.492

7.  Misuse of "light" cigarettes by means of vent blocking.

Authors:  L T Kozlowski; J L Pillitteri; C T Sweeney
Journal:  J Subst Abuse       Date:  1994

8.  Carcinogen exposure during short-term switching from regular to "light" cigarettes.

Authors:  Neal L Benowitz; Peyton Jacob; John T Bernert; Margaret Wilson; Langing Wang; Faith Allen; Delia Dempsey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-06       Impact factor: 4.254

9.  Reduced nicotine content cigarettes and nicotine patch.

Authors:  Dorothy K Hatsukami; Louise A Hertsgaard; Rachel I Vogel; Joni A Jensen; Sharon E Murphy; Stephen S Hecht; Steven G Carmella; Mustafa al'Absi; Anne M Joseph; Sharon S Allen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-19       Impact factor: 4.254

10.  Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.

Authors:  Dorothy K Hatsukami; Michael Kotlyar; Louise A Hertsgaard; Yan Zhang; Steven G Carmella; Joni A Jensen; Sharon S Allen; Peter G Shields; Sharon E Murphy; Irina Stepanov; Stephen S Hecht
Journal:  Addiction       Date:  2010-02       Impact factor: 6.526

View more
  2 in total

1.  The Public Health Gains Had Cigarette Companies Chosen to Sell Very Low Nicotine Cigarettes.

Authors:  David T Levy; K Michael Cummings; Bryan W Heckman; Yameng Li; Zhe Yuan; Tracy T Smith; Rafael Meza
Journal:  Nicotine Tob Res       Date:  2021-02-16       Impact factor: 4.244

2.  'It brings light to what you really put into your body': a focus group study of reactions to messages about nicotine reduction in cigarettes.

Authors:  Hue Trong Duong; Emily E Loud; James F Thrasher; Katherine C Henderson; David L Ashley; Lucy Popova
Journal:  Tob Control       Date:  2021-04-16       Impact factor: 6.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.